Intracerebral hemorrhage (ICH), the most common form of hemorrhagic stroke, accounts for up to 15% of all strokes, with 37,000-52,400 Americans suffering an ICH annually. ICH has the highest acute mortality and the worst long-term neurological outcomes of all types of stroke. ICH is caused by a ruptured blood vessel within the brain, leading to the formation of a space occupying hematoma. Hematoma volume is clinically associated with neurological deterioration and higher mortality;however, many ICH patients are poor surgical candidates and/or present with an unfavorable size/location of the lesion, restricting the utility of neurosurgical intervention. Furthermore, efficacious medical treatment options to promote hematoma clearance are lacking, presenting a critical barrier to clinical practice. Our long-term objective is to identify the molecular and cellular pathways which contribute to clot resolution after ICH. This knowledge will provide a framework for pharmaceutical development to improve patient outcomes after ICH. Our pilot data suggest the curry spice, curcumin, promotes hematoma resolution after ICH and may therefore represent a novel and safe treatment option.
Specific Aim 1 will test the hypothesis that CD36 mediates curcumin-induced hematoma clearance after ICH.
Specific Aim 2 will test the hypothesis that C/EBP-? mediates curcumin-induced CD36 expression and hematoma resolution after ICH. Together, the proposed studies will elucidate the molecular and cellular mechanisms which underlie the ability of curcumin to promote hematoma resolution. The results of these studies will provide a framework for pharmaceutical development targeting C/EBP-? and/or CD36 to improve clinical outcomes after ICH.
Intracerebral hemorrhage (ICH), the most common type of hemorrhage stroke, is induced by a ruptured blood vessel, resulting in the formation of a space-occupying hematoma (blood clot) within the brain. Hematoma volume is associated with increased patient mortality;however, few treatment options are available to eliminate the clot. Given that the rate of ICH incidence is expected to double over the next 50 years as a result of an aging population and increased risk factors (e.g. hypertension, diabetes), novel therapeutic strategies to promote hematoma resolution are needed. The present application will assess the potential for the clinically non-toxic curry spice, curcumin, to promote hematoma resolution and improve outcomes after ICH.
|Sukumari-Ramesh, Sangeetha; Alleyne Jr, Cargill H; Dhandapani, Krishnan M (2016) The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Confers Acute Neuroprotection After Intracerebral Hemorrhage in Mice. Transl Stroke Res 7:141-8|
|Khan, Mohammad Badruzzaman; Hoda, Md Nasrul; Vaibhav, Kumar et al. (2015) Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment. Transl Stroke Res 6:69-77|
|Sukumari-Ramesh, Sangeetha; Prasad, Niyathi; Alleyne, Cargill H et al. (2015) Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells. BMC Cancer 15:118|
|Laird, Melissa D; Shields, Jessica S; Sukumari-Ramesh, Sangeetha et al. (2014) High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 62:26-38|
|King, Melanie D; Alleyne Jr, Cargill H; Dhandapani, Krishnan M (2013) TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice. Neurosci Lett 542:92-6|
|Farook, J M; Shields, J; Tawfik, A et al. (2013) GADD34 induces cell death through inactivation of Akt following traumatic brain injury. Cell Death Dis 4:e754|
|Sukumari-Ramesh, Sangeetha; Alleyne Jr, Cargill H; Dhandapani, Krishnan M (2012) Astrocyte-specific expression of survivin after intracerebral hemorrhage in mice: a possible role in reactive gliosis? J Neurotrauma 29:2798-804|